PULMONX CORPORATION — Operating Income by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/4cceb76a-1a12-4b60-90e1-b6902b753793/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-53.7M | 2025-01-01 – 2025-12-31 | evidence 0001127537-26-000015 |
| FY 2024 | $-57.7M | 2024-01-01 – 2024-12-31 | evidence 0001127537-25-000012 |
| FY 2023 | $-61.9M | 2023-01-01 – 2023-12-31 | evidence 0001127537-24-000024 |
| FY 2022 | $-58.6M | 2022-01-01 – 2022-12-31 | evidence 0001127537-23-000011 |
| FY 2021 | $-47.3M | 2021-01-01 – 2021-12-31 | evidence 0001127537-22-000013 |
| FY 2020 | $-32.3M | 2020-01-01 – 2020-12-31 | evidence 0001127537-21-000008 |
| FY 2019 | $-17.8M | 2019-01-01 – 2019-12-31 | evidence 0001127537-21-000008 |
| FY 2018 | $-15.1M | 2018-01-01 – 2018-12-31 | evidence 0001127537-21-000008 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).